V
GOCO

Veritable’s GoHealth GOCO Stock Holding History

Veritable’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,267
Closed -$11K – 836
2022
Q2 		$11K Buy
+1,267
New +$14.7K ﹤0.01% 901

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Veritable's GOCO Position: Q3 2022 in Review

Veritable sold out of GoHealth (GOCO) in Q3 2022, closing a stake of 1,267 shares — an estimated $11K sold.

Veritable first reported a position in GOCO in Q2 2022 and held it in 1 quarter. The position peaked at $11K in Q2 2022. 59 funds tracked by Wall St. Rank hold GOCO as of Q3 2022.

  • Veritable reported no remaining GoHealth position as of Q3 2022 after selling out during the quarter.
  • Veritable sold 1,267 GoHealth shares in Q3 2022, an estimated $11K.
  • Veritable first reported a position in GoHealth in Q2 2022 and held it in 1 quarter.
  • Veritable's GoHealth position peaked at $11K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held GoHealth as of Q3 2022.

Based on Veritable's 13F filing for Q3 2022, filed 14 Nov 2022.